Cargando…

Relevance of Dynamic (18)F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes

This study evaluates the relevance of (18)F-DOPA PET static and dynamic radiomics for differentiation of high-grade glioma (HGG) progression from treatment-related changes (TRC) by comparing diagnostic performances to the current PET imaging standard of care. Eighty-five patients with histologically...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahrari, Shamimeh, Zaragori, Timothée, Rozenblum, Laura, Oster, Julien, Imbert, Laëtitia, Kas, Aurélie, Verger, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698938/
https://www.ncbi.nlm.nih.gov/pubmed/34944740
http://dx.doi.org/10.3390/biomedicines9121924
_version_ 1784620398196817920
author Ahrari, Shamimeh
Zaragori, Timothée
Rozenblum, Laura
Oster, Julien
Imbert, Laëtitia
Kas, Aurélie
Verger, Antoine
author_facet Ahrari, Shamimeh
Zaragori, Timothée
Rozenblum, Laura
Oster, Julien
Imbert, Laëtitia
Kas, Aurélie
Verger, Antoine
author_sort Ahrari, Shamimeh
collection PubMed
description This study evaluates the relevance of (18)F-DOPA PET static and dynamic radiomics for differentiation of high-grade glioma (HGG) progression from treatment-related changes (TRC) by comparing diagnostic performances to the current PET imaging standard of care. Eighty-five patients with histologically confirmed HGG and investigated by dynamic (18)F-FDOPA PET in two institutions were retrospectively selected. ElasticNet logistic regression, Random Forest and XGBoost machine models were trained with different sets of features—radiomics extracted from static tumor-to-background-ratio (TBR) parametric images, radiomics extracted from time-to-peak (TTP) parametric images, as well as combination of both—in order to discriminate glioma progression from TRC at 6 months from the PET scan. Diagnostic performances of the models were compared to a logistic regression model with TBR(mean) ± clinical features used as reference. Training was performed on data from the first center, while external validation was performed on data from the second center. Best radiomics models showed only slightly better performances than the reference model (respective AUCs of 0.834 vs. 0.792, p < 0.001). Our current results show similar findings at the multicentric level using different machine learning models and report a marginal additional value for TBR static and TTP dynamic radiomics over the classical analysis based on TBR values.
format Online
Article
Text
id pubmed-8698938
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86989382021-12-24 Relevance of Dynamic (18)F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes Ahrari, Shamimeh Zaragori, Timothée Rozenblum, Laura Oster, Julien Imbert, Laëtitia Kas, Aurélie Verger, Antoine Biomedicines Article This study evaluates the relevance of (18)F-DOPA PET static and dynamic radiomics for differentiation of high-grade glioma (HGG) progression from treatment-related changes (TRC) by comparing diagnostic performances to the current PET imaging standard of care. Eighty-five patients with histologically confirmed HGG and investigated by dynamic (18)F-FDOPA PET in two institutions were retrospectively selected. ElasticNet logistic regression, Random Forest and XGBoost machine models were trained with different sets of features—radiomics extracted from static tumor-to-background-ratio (TBR) parametric images, radiomics extracted from time-to-peak (TTP) parametric images, as well as combination of both—in order to discriminate glioma progression from TRC at 6 months from the PET scan. Diagnostic performances of the models were compared to a logistic regression model with TBR(mean) ± clinical features used as reference. Training was performed on data from the first center, while external validation was performed on data from the second center. Best radiomics models showed only slightly better performances than the reference model (respective AUCs of 0.834 vs. 0.792, p < 0.001). Our current results show similar findings at the multicentric level using different machine learning models and report a marginal additional value for TBR static and TTP dynamic radiomics over the classical analysis based on TBR values. MDPI 2021-12-16 /pmc/articles/PMC8698938/ /pubmed/34944740 http://dx.doi.org/10.3390/biomedicines9121924 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ahrari, Shamimeh
Zaragori, Timothée
Rozenblum, Laura
Oster, Julien
Imbert, Laëtitia
Kas, Aurélie
Verger, Antoine
Relevance of Dynamic (18)F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes
title Relevance of Dynamic (18)F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes
title_full Relevance of Dynamic (18)F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes
title_fullStr Relevance of Dynamic (18)F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes
title_full_unstemmed Relevance of Dynamic (18)F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes
title_short Relevance of Dynamic (18)F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes
title_sort relevance of dynamic (18)f-dopa pet radiomics for differentiation of high-grade glioma progression from treatment-related changes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698938/
https://www.ncbi.nlm.nih.gov/pubmed/34944740
http://dx.doi.org/10.3390/biomedicines9121924
work_keys_str_mv AT ahrarishamimeh relevanceofdynamic18fdopapetradiomicsfordifferentiationofhighgradegliomaprogressionfromtreatmentrelatedchanges
AT zaragoritimothee relevanceofdynamic18fdopapetradiomicsfordifferentiationofhighgradegliomaprogressionfromtreatmentrelatedchanges
AT rozenblumlaura relevanceofdynamic18fdopapetradiomicsfordifferentiationofhighgradegliomaprogressionfromtreatmentrelatedchanges
AT osterjulien relevanceofdynamic18fdopapetradiomicsfordifferentiationofhighgradegliomaprogressionfromtreatmentrelatedchanges
AT imbertlaetitia relevanceofdynamic18fdopapetradiomicsfordifferentiationofhighgradegliomaprogressionfromtreatmentrelatedchanges
AT kasaurelie relevanceofdynamic18fdopapetradiomicsfordifferentiationofhighgradegliomaprogressionfromtreatmentrelatedchanges
AT vergerantoine relevanceofdynamic18fdopapetradiomicsfordifferentiationofhighgradegliomaprogressionfromtreatmentrelatedchanges